Department of Pathology, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Pathol Res Pract. 2010 May 15;206(5):305-9. doi: 10.1016/j.prp.2010.01.007. Epub 2010 Mar 1.
In this study, we evaluated the immunohistochemical expression and the possible advantages of Ki67 antigen, c-erbB-2, and c-kit proto-oncogenes in the differentiation between benign and malignant pheochromocytomas. Paraffin-embedded tissue blocks from 44 benign (35 adrenal and 9 extra-adrenal) and 11 malignant (9 adrenal and 2 extra-adrenal) cases of pheochromocytoma were selected for immunohistochemical staining using antibodies against Ki67, c-erbB-2, and c-kit antigens. We investigated the relationship between the expression of these antigens and age, gender, tumor size, histologic patterns and necrosis, as well as tumor behavior. The risk of malignancy was higher when tumor size was increased. We found out that more uncommon tissue patterns, such as small cell and spindle cell patterns, are mostly indicators of malignancy. There was a statistically significant relationship between Ki67- and c-erbB-2-positive staining of the tumor cells and the malignant behavior of the pheochromocytomas (p-value=0.000), while cytoplasmic c-kit staining did not show any correlation with tumor malignancy (p-value=0.087). We concluded that tumor size and the histomorphologic patterns (spindle cell and small round cell) are significantly associated with tumor behavior. In addition, Ki67 positivity and c-erbB-2 expression can be used as immunohistochemical markers for predicting the malignant behavior of pheochromocytoma.
在这项研究中,我们评估了 Ki67 抗原、c-erbB-2 和 c-kit 原癌基因在良恶性嗜铬细胞瘤鉴别诊断中的免疫组织化学表达和可能的优势。选择 44 例良性(35 例肾上腺和 9 例肾上腺外)和 11 例恶性(9 例肾上腺和 2 例肾上腺外)嗜铬细胞瘤的石蜡包埋组织块,用针对 Ki67、c-erbB-2 和 c-kit 抗原的抗体进行免疫组织化学染色。我们研究了这些抗原的表达与年龄、性别、肿瘤大小、组织学模式和坏死以及肿瘤行为之间的关系。当肿瘤增大时,恶性风险更高。我们发现,更不常见的组织模式,如小细胞和梭形细胞模式,大多是恶性的指标。肿瘤细胞 Ki67 和 c-erbB-2 阳性染色与嗜铬细胞瘤的恶性行为之间存在统计学显著关系(p 值=0.000),而细胞质 c-kit 染色与肿瘤恶性程度无相关性(p 值=0.087)。我们得出结论,肿瘤大小和组织形态学模式(梭形细胞和小圆细胞)与肿瘤行为显著相关。此外,Ki67 阳性和 c-erbB-2 表达可用作预测嗜铬细胞瘤恶性行为的免疫组织化学标志物。